Rising Healthcare Costs: Increased Regulation of Physiotherapy and its Impact on Investor Sentiment

On February 27, 2026, a strengthening of regulations within the healthcare sector is underway, with patients expected to bear a greater out-of-pocket cost for non-covered services such as physiotherapy. This shift has the potential to impact investor sentiment across the healthcare industry, suggesting a possible decline in profitability for related companies.

The Background and Details of Strengthened Healthcare Regulations

According to Mae Kyung, the government is actively pursuing revisions to relevant regulations with the aim of enhancing the quality management of healthcare services. Specifically, the increased regulation of non-covered items like physiotherapy will likely result in patients bearing a higher out-of-pocket cost. This measure is interpreted as an effort to prevent excessive treatment and unnecessary billing practices by medical institutions.

The Impact of Increased Out-of-Pocket Costs on Investor Sentiment

The increase in out-of-pocket costs may lead to a decrease in the frequency of patients utilizing healthcare services. This could translate into reduced revenue for medical institutions offering physiotherapy, amplifying concerns about the deterioration of profitability for related companies. Investors should closely monitor these changes and prepare for the potential decline in stock prices of affected firms.

Outlook for Related Industries

While the strengthening of healthcare regulations may have a negative impact on related industries in the short term, it could contribute to improved quality of healthcare services and the creation of a healthy competitive environment in the long run. Companies that provide innovative medical technologies and services are expected to maintain their competitiveness even after the regulations are strengthened. Investors should consider these factors and develop investment strategies from a long-term perspective.

Investment Strategy Recommendations

• In the short term, it is advisable to refrain from investing in companies directly affected by the strengthened regulations.


• In the long term, consider investing in companies that provide innovative technologies and services.


• Continuous monitoring of changes in healthcare-related policies is necessary.